Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bertz

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|August 28, 2012
Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantationP Urbain, J Birlinger, C Lambert, et al.
Leukemia|August 31, 2016
Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDSH Bertz, M Lübbert, K Ohneberg, et al.
Bone Marrow Transplantation|June 18, 1999
Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donorsC Berger, H Bertz, C Schmoor, et al.
Bone Marrow Transplantation|April 14, 2009
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patientsM Lübbert, H Bertz, B Rüter, et al.
Bone Marrow Transplantation|September 1, 2009
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allograftingM Lübbert, H Bertz, R Wäsch, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcomaS Fetscher, W Brugger, H Bertz, et al.
BMC Cancer|May 4, 2019
It's never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trialS Kneis, A Wehrle, J Müller, et al.
Leukemia|March 18, 2005
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantationR Zeiser, A Spyridonidis, R Wäsch, et al.
Bone Marrow Transplantation|February 5, 2013
Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AMLP Christopoulos, C Schmoor, M Waterhouse, et al.
Cancer|May 1, 1997
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantationF C Dimeo, M H Tilmann, H Bertz, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|August 28, 2012
Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantationP Urbain, J Birlinger, C Lambert, et al.
Leukemia|August 31, 2016
Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDSH Bertz, M Lübbert, K Ohneberg, et al.
Bone Marrow Transplantation|June 18, 1999
Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donorsC Berger, H Bertz, C Schmoor, et al.
Bone Marrow Transplantation|April 14, 2009
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patientsM Lübbert, H Bertz, B Rüter, et al.
Bone Marrow Transplantation|September 1, 2009
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allograftingM Lübbert, H Bertz, R Wäsch, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcomaS Fetscher, W Brugger, H Bertz, et al.
BMC Cancer|May 4, 2019
It's never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trialS Kneis, A Wehrle, J Müller, et al.
Leukemia|March 18, 2005
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantationR Zeiser, A Spyridonidis, R Wäsch, et al.
Bone Marrow Transplantation|February 5, 2013
Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AMLP Christopoulos, C Schmoor, M Waterhouse, et al.
Cancer|May 1, 1997
Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantationF C Dimeo, M H Tilmann, H Bertz, et al.
Pageof 12